Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas
In this episode, hosts discuss optimizing insulin therapy for people with diabetes using AI-driven algorithms with Eran Atlas, CEO of DreaMed Diabetes.
In this episode, hosts discuss optimizing insulin therapy for people with diabetes using AI-driven algorithms with Eran Atlas, CEO of DreaMed Diabetes.
All the weird and wonderful fitness tech from CES
This cross-sectional study evaluates the approval status and timeline and therapeutic value of urgently needed overseas drugs in China.
This cohort study examines the association of treatment with metformin and add-on antidiabetic medications with asthma attacks.
The rheumatology month in review emphasizes new research in PsA and on cardiovascular events in rheumatic disease.
You can’t buy these cool concepts yet, but they might eventually land in a store near you.
Heat stroke is characterised by hyperthermia and acute encephalopathy. We describe a rare case of classical heat stroke secondary to prolonged sauna use with multiorgan…
A major expansion of the private sector’s role in providing elective NHS care in England risks diverting finite staff and resources from elsewhere in the…
ZDNET is live from Las Vegas, covering the best and most innovative mobile accessories at CES 2025. Here are our top picks so far.
Objectives To explore the impact of the SARS-CoV-2/COVID-19 pandemic on the diagnosis, management and patient journey for children and young people with a newly diagnosed…
Zoplar has secured $3.4 Mn in a Series A funding round led by Blume Ventures, along with participation from other investors.